Highlights

  • Macquarie maintains positive ratings across all four stocks, spanning healthcare, telecom, retail, and agribusiness
  • PME represents high-growth healthcare technology exposure with strong contract momentum
  • TPG and COL provide Earnings stability, while BGA reflects cyclical upside potential

Macquarie Research’s coverage across select ASX-listed companies continues to reflect a broadly constructive stance on a diversified group of stocks spanning healthcare technology, telecommunications, consumer staples, and agribusiness. While each company operates in distinct industry cycles, the common thread in Macquarie’s positioning is a preference for earnings visibility, structural growth drivers, and medium-term operational momentum.

This multi-stock review assesses four ASX names—Bega Cheese (ASX:BGA), Pro Medicus (ASX:PME), TPG Telecom (ASX:TPG), and Coles Group (ASX:COL)—through the lens of broker optimism, recent financial performance, and forward-looking sector dynamics.

Bega Cheese (ASX:BGA): Margin Recovery Story in a Commodity Cycle

Bega Cheese has been navigating a period of improving profitability, supported by stronger branded product performance and a shift toward higher-value product mix in ingredients and nutritionals.

Recent results highlight a rebound in earnings, with EBITDA rising meaningfully year-on-year and EPS growth supported by operational improvements across branded segments. Growth in international branded sales and expanding “better-for-you” product categories have been key drivers.

However, the bulk dairy segment remains exposed to commodity pricing dynamics, farmgate milk costs, and export competition. This introduces earnings variability that is typical of agribusiness operators.

Macquarie’s positive stance reflects expectations that operational improvements and branded portfolio expansion will partially offset commodity Volatility over time.

The Investment narrative remains centred on cyclical recovery combined with gradual structural Brand strength development.

Pro Medicus (ASX:PME): High-Margin Healthcare Software Compounder

Pro Medicus remains one of the strongest-performing healthcare software companies on the ASX, driven by sustained contract wins across major hospital systems and academic medical centres.

Recent announcements show continued momentum in long-term contracts, often spanning five to ten years, reinforcing Revenue visibility and recurring earnings strength. Revenue growth remains robust, supported by high operating margins and strong cash generation.

The Business model is characterised by scalable cloud-based imaging software, with limited incremental cost per additional customer, contributing to elevated profitability levels relative to peers.

Macquarie’s Outperform view reflects confidence in ongoing contract momentum, international expansion, and the durability of Demand for advanced medical imaging software.

The key long-term consideration remains contract renewal cycles and competition in high-end imaging software platforms.

TPG Telecom (ASX:TPG): Mobile-Led Transition and Cash Flow Focus

TPG Telecom has undergone a structural transformation toward a mobile-focused operating model following asset divestments and network expansion initiatives.

Recent results indicate improving mobile subscriber growth, supported by regional network expansion and stronger digital brand performance. EBITDA growth has been driven by both revenue expansion and disciplined cost control.

The company has also undertaken significant Capital management initiatives, including large-scale capital returns and Debt reduction, which have improved Balance Sheet flexibility.

However, earnings growth remains moderate, reflecting competitive pressures in the Australian telecommunications sector and structural limitations in fixed-line markets.

Macquarie’s Outperform rating is anchored in expectations of steady mobile revenue expansion and improving free cash flow generation over time.

Coles Group (ASX:COL): Defensive Earnings With Emerging Cost Pressures

Coles continues to demonstrate stable supermarket performance, supported by consistent demand for essential goods and strong execution in core retail operations.

Recent trading updates show steady supermarket sales growth, supported by Volume increases and rising eCommerce penetration. Online grocery remains a structural growth driver, with increasing adoption across customer segments.

However, rising input costs—including fuel, freight, and packaging—are creating pressure on margins. The Liquor segment has also shown weaker performance due to softer consumer sentiment.

The business remains highly defensive, operating within a duopolistic supermarket structure that supports stable demand but limits pricing flexibility.

Macquarie’s positive view reflects expectations of continued earnings stability and defensive cash flow characteristics, even in a higher-cost environment.

Conclusion

Macquarie’s broadly optimistic stance across Bega Cheese, Pro Medicus, TPG Telecom, and Coles Group reflects a diversified preference for earnings visibility, structural growth exposure, and defensive cash flow stability. While each stock operates within different cyclical and structural dynamics, the common investment thread is a focus on companies with either improving operational momentum or durable revenue streams. The overall positioning suggests a balanced portfolio tilt rather than concentrated sector conviction, spanning high-growth healthcare technology, stable telecom and retail earnings, and cyclical agribusiness recovery potential.